CDC vaccine panel to meet in March after delay
Source: SeekingAlpha
2026-02-24 12:06:38 ET
More on Pfizer, Merck, etc.
- Merck: Why Investors Should Remain Bullish Despite Patent Risks
- Pfizer: A Risky 6.3% Yield For Income-Oriented Investors
- Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades)
- GSK inks licensing deal worth up to $1B with China’s Frontier Bio
- Pfizer strikes $495M deal for obesity drug rights in China
Read the full article on Seeking Alpha
For further details see:
CDC vaccine panel to meet in March after delay
Moderna Inc.
NASDAQ: MRNA
MRNA Trading
1.4% G/L:
$54.50 Last:
3,621,646 Volume:
$55.0309 Open:
MRNA Latest News
MRNA Stock Data
$16,877,354,918
348,095,445
0.39%
298
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
